Tissue engineering technology has advanced rapidly in recent years, offering opportunities
to construct biologically active tissues or organ substitutes to repair or even enhance the …

Over the past decade, the emergence of patient-derived tumor organoids (PDTOs) has
broadened the repertoire of preclinical models and progressively revolutionized three …

Organ-on-a-Chip (OOC) technology, which emulates the physiological environment and
functionality of human organs on a microfluidic chip, is undergoing significant technological …

The extracellular matrix (ECM) of solid tumors impacts the antitumor activities of CD8+ T and
natural killer (NK) cells in a variety of ways. Cell motility is restricted by the tumor ECM which …

Silver nanoparticles (AgNPs) garnered significant attention and applications in the field of
nanotechnology due to their unique physicochemical properties. However, with the …

Biohybrid regenerative bioelectronics are an emerging technology combining implantable
devices with cell transplantation. Once implanted, biohybrid regenerative devices integrate …

Organoids are miniature, highly accurate representations of organs that capture the structure
and unique functions of specific organs. Although the field of organoids has experienced …

Abstract 3D in vitro model has emerged as a valuable tool for studying tissue development,
drug screening, and disease modeling. 3D systems can accurately replicate tissue …

Tissue engineering, an interdisciplinary field, aims to restore, maintain, or enhance tissue
function by developing biological substitutes. To establish an optimal microenvironment …

While tumor organoids have revolutionized cancer research by recapitulating the cellular
architecture and behaviors of real tumors in vitro, their lack of functional vasculature hinders …